Did you know that Alphabet Inc (NASDAQ:GOOG, NASDAQ:GOOGL) went skidding into the end of 2017? Some investors may not have noticed the underperformance in Google stock, as it stumbled up to and through the holiday trading periods. On Dec. 18, Alphabet stock leaped to new all-time highs, before d
Maybe the election is over and maybe we all have to get back to work. What is not over is that the current Powerball jackpot has reached a massive $320 million. Maybe this is a lower amount at $202 million for the cash value lump-sum payment, but either way it is empire making money that can create multi-generational wealth.
With the drawing set for Saturday, November 19, the reality is that....More>>>
Idera Pharmaceuticals Inc. (NASDAQ: IDRA) is focused on cancer and rare diseases, and it could be a what traders refer to as a three-bagger or four-bagger, if two analysts who made key calls in recent days end up being correct here. As it has a market cap of just about $370 million, investors need to consider that they likely are taking far greater risk in Idera than with established biotech and....More>>>
Boring industries and small-capitalization stocks are two things that are very rarely found together. If you search the ranks of the hottest or most promising small-cap stocks, you will find mostly technology and biotech.
So, when I stumbled upon Fuling Global (NASDAQ:FORK), a Chinese manufacturer of plastic cutlery, plates, cups, straws, and similar products, the valuation....More>>>
Related Benzinga's Option Alert Recap From August 4 Report Says Google Was Once Interested In Acquiring Snap Last Year Related GS Analyst Thinks Lending Club Deserves More Credit, Upgrades To Outperform BMO Capital Says It's Closing The Pair Trade On Wells Fargo And Citigroup US Market Indexes....More>>>
Some analysts cite Hillary Clinton’s continued criticism of drug prices as a cause for a slump in biotech during the U.S. presidential campaign, but with the election behind us, many biotech enterprises saw at least a 9% increase due to Donald Trump’s victory.
Two companies in the biotech space entering the first quarter of 2017 may be in a position for their products, as well....More>>>
On Thursday, our Elite Opportunity Pronewsletter suggested getting into Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA: LABU) in part totake advantage of the January effect:
As a matter of fact, the entire biotech sector was the big performer yesterday, so we’re going to go ahead and take another shot with LABU, one of the primary bullish leveraged ETF’s tracking the....More>>>
Shares of Inovio Pharmaceuticals(INO) are climbing today after the biotech company announced that it would begin testing a Zika vaccine in Puerto Rico. Maxim’sJason McCarthy andJason Kolbert have the details:
CREDIT: Alex Wild Published Credit: Alex Wild Alex Wild
Inovio announced the initiation of a small clinical study (N=160) of its Zika vaccine, GLS-5700 (being developed....More>>>
Shares of Control4 (NASDAQ:CTRL), a leading provider of automation and networking systems for homes and businesses that boasts products to personalize control of music, video, lighting, comfort, security, and communications as an entire premium smart home system, are soaring 20% higher on Friday as of 1:40 p.m. EST.
The surge in price was fueled by the company’s....More>>>
A pile of rusty pipes and materials are all that remain of Lanzhou New Area’s tram project. Only a year ago it was a flagship public-private partnership for the planned city in Central China, before it fell victim to President Xi Jinping’s debt clampdown.